Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
Needle threading failed. Just kinda comes off as the same people who can’t fathom having any issues to resolve beyond “just eat less bro, anyone can do it! You’re just a fat fuck that’s too lazy to fix it”. Especially with that shitty strawman of a cartoon.